Correlation Between Hepion Pharmaceuticals and Caribou Biosciences

Can any of the company-specific risk be diversified away by investing in both Hepion Pharmaceuticals and Caribou Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hepion Pharmaceuticals and Caribou Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Hepion Pharmaceuticals and Caribou Biosciences, you can compare the effects of market volatilities on Hepion Pharmaceuticals and Caribou Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hepion Pharmaceuticals with a short position of Caribou Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hepion Pharmaceuticals and Caribou Biosciences.

Diversification Opportunities for Hepion Pharmaceuticals and Caribou Biosciences

-0.11

Correlation Coefficient

Hepion Pharmaceuticals  Caribou Biosciences

Good diversification

The 3 months correlation between Hepion and Caribou is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Hepion Pharmaceuticals and Caribou Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Caribou Biosciences and Hepion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hepion Pharmaceuticals are associated (or correlated) with Caribou Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Caribou Biosciences has no effect on the direction of Hepion Pharmaceuticals i.e., Hepion Pharmaceuticals and Caribou Biosciences go up and down completely randomly.

Pair Corralation between Hepion Pharmaceuticals and Caribou Biosciences

Given the investment horizon of 90 days Hepion Pharmaceuticals is expected to under-perform the Caribou Biosciences. In addition to that, Hepion Pharmaceuticals is 1.12 times more volatile than Caribou Biosciences. It trades about -0.05 of its total potential returns per unit of risk. Caribou Biosciences is currently generating about 0.03 per unit of volatility. If you would invest  216.00  in Caribou Biosciences on August 30, 2024 and sell it today you would earn a total of  4.00  from holding Caribou Biosciences or generate 1.85% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Hepion Pharmaceuticals  vs.  Caribou Biosciences

Hepion Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Hepion Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Caribou Biosciences

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Caribou Biosciences are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental drivers, Caribou Biosciences may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pair Trading with Hepion Pharmaceuticals and Caribou Biosciences

The main advantage of trading using opposite Hepion Pharmaceuticals and Caribou Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hepion Pharmaceuticals position performs unexpectedly, Caribou Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Caribou Biosciences will offset losses from the drop in Caribou Biosciences' long position.

The idea behind Hepion Pharmaceuticals and Caribou Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..